In my opinion the main concern with the IND is about de-risking. Until we have an approved IND we can't run a trial in the US. Our original IND application was not approved, so it's obviously more than just a formality. I feel it's a significant box to have ticked and may also be viewed with enthusiasm by the market.
Once we have IND approval we wouldn't need to start a trial immediately if it didn't make sense to do so, but at least we would have passed that regulatory hurdle.
In my opinion the main concern with the IND is about de-risking....
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 8662 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |